Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shore

Showing results (401-410 of 422) with videos related to

Pageof 43
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 8, 2018
Discovery of potent azaindazole leucine-rich repeat kinase 2 (LRRK2) inhibitors possessing a key intramolecular hydrogen bond - Part 2Daniel G M Shore, Zachary K Sweeney, Alan Beresford, et al.
Autism : the International Journal of Research and Practice|June 2, 2022
Learning from the experts: Evaluating a participatory autism and universal design training for university educatorsT C Waisman, Zachary J Williams, Eilidh Cage, et al.
Autism : the International Journal of Research and Practice|May 21, 2020
Listening to the autistic voice: Mental health priorities to guide research and practice in autism from a stakeholder-driven projectTeal W Benevides, Stephen M Shore, Kate Palmer, et al.
Journal of Medicinal Chemistry|October 2, 2014
CB2-selective cannabinoid receptor ligands: synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamidesValentina Lucchesi, Dow P Hurst, Derek M Shore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II StudyMorris Kletzel, Howard M Katzenstein, Paul R Haut, et al.
Autism : the International Journal of Research and Practice|May 12, 2020
Interventions to address health outcomes among autistic adults: A systematic reviewTeal W Benevides, Stephen M Shore, May-Lynn Andresen, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2016
Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-onesMaria Elena Meza-Aviña, Mary A Lingerfelt, Linda M Console-Bram, et al.
Haematologica|March 19, 2026
Phase I study of the safety and pharmacokinetics of CSL889 (hemopexin) in adults with sickle cell anemiaBart J Biemond, Rachel Kesse-Adu, Ezanul Wahab, et al.
Biochemistry|November 27, 2013
Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligandsEvangelia Kotsikorou, Haleli Sharir, Derek M Shore, et al.
European Journal of Human Genetics : EJHG|January 22, 2015
Clinical Utility Gene Card for: Fibrodysplasia ossificans progressivaNathalie Bravenboer, Dimitra Micha, James T Triffit, et al.
Pageof 43

Showing results (401-410 of 422) with videos related to

Sort By:
Pageof 43
Bioorganic & Medicinal Chemistry Letters|December 8, 2018
Discovery of potent azaindazole leucine-rich repeat kinase 2 (LRRK2) inhibitors possessing a key intramolecular hydrogen bond - Part 2Daniel G M Shore, Zachary K Sweeney, Alan Beresford, et al.
Autism : the International Journal of Research and Practice|June 2, 2022
Learning from the experts: Evaluating a participatory autism and universal design training for university educatorsT C Waisman, Zachary J Williams, Eilidh Cage, et al.
Autism : the International Journal of Research and Practice|May 21, 2020
Listening to the autistic voice: Mental health priorities to guide research and practice in autism from a stakeholder-driven projectTeal W Benevides, Stephen M Shore, Kate Palmer, et al.
Journal of Medicinal Chemistry|October 2, 2014
CB2-selective cannabinoid receptor ligands: synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamidesValentina Lucchesi, Dow P Hurst, Derek M Shore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II StudyMorris Kletzel, Howard M Katzenstein, Paul R Haut, et al.
Autism : the International Journal of Research and Practice|May 12, 2020
Interventions to address health outcomes among autistic adults: A systematic reviewTeal W Benevides, Stephen M Shore, May-Lynn Andresen, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2016
Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-onesMaria Elena Meza-Aviña, Mary A Lingerfelt, Linda M Console-Bram, et al.
Haematologica|March 19, 2026
Phase I study of the safety and pharmacokinetics of CSL889 (hemopexin) in adults with sickle cell anemiaBart J Biemond, Rachel Kesse-Adu, Ezanul Wahab, et al.
Biochemistry|November 27, 2013
Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligandsEvangelia Kotsikorou, Haleli Sharir, Derek M Shore, et al.
European Journal of Human Genetics : EJHG|January 22, 2015
Clinical Utility Gene Card for: Fibrodysplasia ossificans progressivaNathalie Bravenboer, Dimitra Micha, James T Triffit, et al.
Pageof 43